Cytotoxic T-lymphocyte antigen-4 single nucleotide polymorphisms are not associated with outcomes after unrelated donor transplantation: a center for international blood and marrow transplant research analysis.

Sengsayadeth S, Wang T, Lee SJ, Haagenson MD, Spellman S, Fernandez ViƱa MA, Muller CR, Verneris MR, Savani BN, Jagasia M
Biol Blood Marrow Transplant. 2014 20 (6): 900-3

PMID: 24631737 · PMCID: PMC4034271 · DOI:10.1016/j.bbmt.2014.03.005

Cytotoxic T-lymphocyte antigen-4 (CTLA-4) plays an essential role in T cell homeostasis by restraining immune responses. AG and GG genotypes of donor CTLA-4 SNP rs4553808 in patients after unrelated donor hematopoietic stem cell transplantations (HSCT) have been shown to be an independent predictor of inferior relapse-free survival (RFS) and overall survival (OS) compared with those with the AA genotype, in single-center studies. We tested the hypothesis that SNP rs4553808 is associated with RFS, OS, nonrelapse mortality (NRM) and the cumulative incidence of acute graft-versus-host disease (GVHD) and chronic GVHD in adults with acute myeloid leukemia and advanced myelodysplastic syndrome undergoing a first 8/8 or 7/8 HLA-matched unrelated donor HSCT. Multivariable analysis adjusting for relevant donor and recipient characteristics showed no significant association between SNP rs4553808 and OS, RFS, NRM, and incidence of acute and chronic GVHD. An exploratory analysis of other CTLA-4 SNPs, as well as studying the interaction with antithymocyte globulin, also demonstrated no significant associations. Our results indicate that CTLA-4 SNPs are not associated with HSCT outcomes.

Published by Elsevier Inc.

MeSH Terms (16)

Adolescent Adult Aged CTLA-4 Antigen Female Hematopoietic Stem Cell Transplantation Humans Leukemia, Myeloid, Acute Male Middle Aged Multivariate Analysis Myelodysplastic Syndromes Polymorphism, Single Nucleotide Treatment Outcome Unrelated Donors Young Adult

Connections (1)

This publication is referenced by other Labnodes entities: